Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index; 7 of the 20 sources its claims cite were checked for support.
Abstract
Background: Adolescents with polycystic ovary syndrome (PCOS) are at increased risk of impaired glucose tolerance (IGT) and type 2 diabetes mellitus. The aim of this study is to evaluate dysglycemia and biochemical differences based on BMI status and assess the prognostic ability of elevated hemoglobin A1c (HbA1c) in predicting an abnormal 2 hour oral glucose tolerance test (OGTT). Methods: Retrospective cohort of female patients aged 11-18 years who underwent 75-g OGTT and were evaluated for PCOS at an urban tertiary care hospital between January 2002 to December 2017. Results: In 106 adolescents with PCOS who had OGTT results available, IGT was markedly pronounced in the ≥95th percentile BMI group (17 out of 72; 23.6%) compared with <95th percentile BMI group (4 out of 34; 11.7%). One patient with obesity met the criteria for type 2 diabetes. Patients with obesity had significantly higher homeostasis model assessment (HOMA-IR) and lower whole body insulin sensitivity index (WBISI) (p < 0.001) compared to patients without obesity. Free testosterone levels were also higher in patients with obesity (p< 0.03) and were significantly associated with HOMA-IR when controlling for body mass index (BMI). HbA1c did not demonstrate a strong ability to predict abnormal OGTT on receiver operating characteristic (ROC) curve analysis [Area under the curve (AUC) = 0.572, 95% CI: 0.428, 0.939]). Conclusions: In a study to assess glucose abnormalities in adolescents with PCOS, IGT was found to be markedly increased in patients with obesity, with abnormal glucose metabolism identified in over one-fifth of the patients. HbA1c alone may be a poor test to assess IGT and we recommend that adolescents diagnosed with PCOS and obesity undergo formal oral glucose tolerance testing.
Overview
CoChat Summary
TL;DR
In 106 adolescents with PCOS who underwent a 75-g OGTT, impaired glucose tolerance was more common in those with BMI ≥95th percentile (23.6%) than in those with BMI <95th percentile (11.7%). HbA1c alone poorly predicted an abnormal 2-hour OGTT, and the authors recommend formal OGTT for adolescents with PCOS and obesity.
Key findings
- Abnormal 2-hour OGTT occurred in 21.6% of the total cohort; IGT was present in 17/72 (23.6%) of patients with BMI ≥95th percentile versus 4/34 (11.7%) of those with BMI <95th percentile. One patient with obesity met criteria for type 2 diabetes (2-hour glucose 273 mg/dl, HbA1c 8.1%).
- Patients with obesity had higher insulin resistance and lower insulin sensitivity than patients without obesity: median HOMA-IR 4.02 vs 1.79 and median WBISI 2.00 vs 5.13 (p < 0.001 for both).
- Free testosterone was higher in patients with obesity (median 7.90 vs 4.70 ng/dl, p = 0.026) and remained significantly associated with HOMA-IR when controlling for BMI (β = 0.151, 95% CI 0.033–0.269, p = 0.014).
- HbA1c did not strongly predict abnormal 2-hour OGTT on ROC analysis (AUC = 0.572, 95% CI 0.428–0.939); IGT proportions did not differ significantly between normal and abnormal HbA1c groups (20.3% vs 30%, p = 0.310).
Methods
- Retrospective cohort of female patients aged 11–18 years diagnosed with PCOS and evaluated at pediatric endocrinology clinics of an urban tertiary academic medical center between January 2002 and December 2017.
- Of 286 patients identified with PCOS, 128 met initial inclusion criteria; 22 were excluded for metformin treatment, leaving 106 patients who underwent OGTT for final analysis. PCOS was defined by Androgen Excess Society 2009 criteria; obesity was BMI ≥95th percentile; OGTT categories used ADA criteria.
- Data included OGTT glucose/insulin values, HbA1c, testosterone, BMI, and blood pressure. Analyses used median [IQR], Chi-squared/Fisher exact tests, Wilcoxon rank-sum tests, ROC curve for HbA1c predicting abnormal OGTT, and linear regressions for testosterone with HOMA-IR/WBISI, performed in R 3.5.3.
Limitations
- Stated: the retrospective design did not allow systematic assessment of all patients, and the decision to perform glucose screening was provider dependent.
- Stated: no comparative non-PCOS control group was included.
- Stated/evident: only patients who had undergone formal OGTT were included, so the true prevalence of glucose abnormalities may be higher; HbA1c and OGTT results were both available in only 89/106 patients, and the single tertiary urban center may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
6 Valid · 3 Not valid · 6 Not checked · 25 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In this study, no differences were observed in two-hour insulin, high-density lipoprotein, and testosterone levels in adolescents with IGT despite the marked difference in BMI.”
§ Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity > Background
What the sources say
- Partly supportedcites [5] Flannery CA, Rackow B, Cong X, Duran E, Selen DJ, Burgert TS, et al. Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI. Pediatr Diabetes. 2013;14(1):42–9. sourceExperimental — accuracy not yet measured
The Results section, “Comparison between NOB-IGT and OB subjects,” reports similar two-hour insulin, HDL, and testosterone levels despite a significant BMI difference. But it compares non-obese adolescents with IGT against the overall obese cohort, not specifically against obese adolescents with IGT, as the claim could imply. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Impaired glucose tolerance occurred more frequently in subjects in the >95th percentile BMI group (17 out of 72, 23.6% when compared to those in the <95th percentile BMI group (4 out of 34, 11.7%) ) (Table 2).”
§ Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity > Results
plainstates an associationn = 72- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In line with the findings of a previous study [5], we found that IGT was the most common glucose abnormality on the OGTT, emphasizing the importance of lifestyle changes and maintaining a healthy BMI in patients with PCOS.”
§ Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“An abnormal two-hour OGTT was found in over one-fifth (21.6%) of our total patient population (Fig. 1).”
- Also stated in: § Discussion · plain
“Over one-fifth of our adolescent cohort was found to have IGT.”
§ Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity > Results
plainn = 106- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Those with obesity also had significantly higher free testosterone levels compared to patients without obesity [7.90 ng/dl (interquartile range 3.92–11) vs. 4.70 ng/dL (interquartile range 2.30–8.25), p = 0.025] (Fig. 2C).”
§ Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
11 more claims
Create a free account to see all 40 claims and every source verdict.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 16
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity > Results
“An abnormal two-hour OGTT was found in over one-fifth (21.6%) of our total patient population (Fig. 1).”
§ Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity > Results
“| Impaired Glucose Tolerance | 4 (11.7%) | 17 (23.6%) | | | Type 2 Diabetes Mellitus | 0 (0.00%) | 1 (1.4%) | |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity > Discussion
“with over one-fourth of these patients meeting the criteria for IGT.”
§ Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity > Abstract > Results
“IGT was markedly pronounced in the ≥95th percentile BMI group (17 out of 72; 23.6%)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity > Discussion
“Over one-fifth of our adolescent cohort was found to have IGT.”
§ Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity > Results
“| Impaired Glucose Tolerance | 4 (11.7%) | 17 (23.6%) | |”
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“The homeostasis model assessment (HOMA-IR) and wholebody insulin sensitivity index (WBISI) calculations were performed to assess insulin resistance [19, 20].”
MethodToprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · cited 1×
“Definitions PCOS was defined as per the Androgen Excess Society (AES) 2009 criteria which includes presence of hyperandrogenism (clinical and/or biochemical), ovarian dysfunction (oligo-anovulation and/or polycystic ovaries), and the exclusion of related disorders [1].”
MethodMarch, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T., & Sekikawa, A. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.920 · Cited by 1,165
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020 · cited 1×
“In addition, abnormal glucose metabolism in PCOS is associated with many of the known risk factors for metabolic syndrome [14, 15], which needs close examination.”
BackgroundAssessment of insulin sensitivity/resistance
Gutch, M., Kumar, S., Razi, S., Gupta, K., & Gupta, A. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.146874 · Cited by 555 · cited 1×
“The homeostasis model assessment (HOMA-IR) and wholebody insulin sensitivity index (WBISI) calculations were performed to assess insulin resistance [19, 20].”
MethodCarmina, E., & Lobo, R. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5803 · Cited by 528
A1c versus glucose testing: a comparison
Sacks, D. B. (2011) · Diabetes Care · doi:10.2337/dc10-1546 · Cited by 461 · cited 1×
“For patients who underwent both OGTT and HbA1c screening, both tests had to be performed within within a three-month time frame [12, 17].”
Method
Cited by
Insulin resistance, metabolic syndrome and polycystic ovaries: an intriguing conundrum
Prosperi, S., & Chiarelli, F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1669716 · Cited by 72
Treatment and complications of PCOS in adolescents - what’s new in 2023?
Jakubowska-Kowal, K. M., Skrzyńska, K., & Gawlik, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1436952 · Cited by 17
Sun, Z., Jin, B., Han, H., Qin, Z., Shi, Y., & Zhang, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1661806 · Cited by 6
Swauger, S. E., & Crimmins, N. A. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.04.184 · Cited by 5
The Natural History of Prediabetes and Cardiovascular Disease in the Pediatric Population
Accacha, S. D., Barillas, J., Gabriel, L., Srivastava, A., Gulkarov, S., Apsan, J., Leon, J. D., & Reiss, A. B. (2026) · Biomedicines · doi:10.3390/biomedicines14010198 · Cited by 4
Metadata
- Authors
- Gupta, J., Antal, Z., Mauer, E., Gerber, L. M., An, A., & Censani, M.
- Affiliations
- NewYork–Presbyterian Hospital (US)
- Weill Cornell Medicine (US)
- Corresponding author
- Censani, Marisa
- Venue
- BMC Endocrine Disorders
- Published
- 2022-07-16
- Volume
- 22
- Issue
- 1
- Pages
- 180-180
- ISSN
- 1472-6823 (ISSN-L)
- PMC
- PMC9288674
- OpenAlex
- W4285587339
- Cited by
- 9
- References
- 28
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2023: 1
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Endocrine Disorders (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR002384)
- National Center for Advancing Translational Sciences (TR002384)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, adolescents, impaired glucose tolerance, type 2 diabetes, obesity, dysglycemia, oral glucose tolerance test, HbA1c, insulin resistance, HOMA-IR, free testosterone, body mass index
- MeSH terms
- Adolescent, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Retrospective Studies, Body Mass Index, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity. https://app.cochat.ai/papers/10.1186/s12902-022-01098-0
- The paper
- Gupta, J., Antal, Z., Mauer, E., Gerber, L. M., An, A., & Censani, M. (2022). Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-022-01098-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.